MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 62 filers reported holding MEI PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | – | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
| DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
| NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
| Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
| BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
| Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
| CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
| Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
| Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
| Sigma Planning Corp | 641,050 | $248,000 | 0.01% |